Freshfields, Kirkland Advise On Advent's $4.7B Zentiva Sale
By Al Barbarino · September 11, 2025, 5:30 PM EDT
European generics pharmaceutical company Zentiva will be sold by private equity firm Advent to U.S.-based GTCR, Advent announced Thursday....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login